Upgrade to SI Premium - Free Trial

RBC Capital Reiterates Outperform Rating on Eli Lilly (LLY)

July 1, 2026 7:59 AM
RBC Capital analyst Trung Huynh reiterated an Outperform rating and $1,250.00 price target on Eli Lilly (NYSE: LLY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments